The recent FDA Fast Track designation for BioRestorative Therapies' BRTX-100 program marks a significant milestone in the treatment of chronic lumbar disc disease (cLDD). Given the debilitating nature of cLDD and its prevalence among middle-aged Americans, this development has sparked
The possibility of creating complex three-dimensional human tissues from diverse biological materials has always been an intriguing concept within medical research. The groundbreaking innovation known as the Electrospider, developed by Bio3DPrinting, a spinoff from Italy's University of Pisa,
Tourette syndrome is a complex condition marked by involuntary motor and vocal tics, significantly impacting the lives of those affected. For years, the medical community has struggled to find an effective treatment that targets the root cause of these symptoms. This struggle has led to the
Ivan Kairatov is a Biopharma expert with deep knowledge of technology and innovation in the industry, with experience in research and development. Today, we discuss the recent FDA approval of adaptive deep brain stimulation (aDBS) as a new treatment option for Parkinson’s disease. Can you explain w
The transformative role of artificial intelligence (AI) and deep learning (DL) in the realm of medical imaging is ushering in a new era for the diagnosis and prognosis of oral potentially malignant disorders (OPMDs). These technologies are spearheading advancements in early detection and risk
In this interview, we are pleased to welcome Ivan Kairatov, a Biopharma expert with deep knowledge of tech and innovation in the industry and extensive experience in research and development, particularly in gene therapy for sensory disorders. Today, Ivan will share insights on the recent positive